Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression

Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported al...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) Jg. 27; H. 1; S. 132 - 10
Hauptverfasser:	Premraj, Lavienraj, Camarda, Christopher, White, Nicole, Godoy, Daniel Agustin, Cuthbertson, Brian H., Rocco, Patricia R. M., Pelosi, Paolo, Robba, Chiara, Suarez, Jose I., Cho, Sung-Min, Battaglini, Denise
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 01.04.2023 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Acute Stroke Management Artificial respiration Brain Ischemia Care and treatment Cerebral Hemorrhage Critical Care Critical Care Medicine Critical Illness Critically ill Emergency Medicine Extubation Female Haemorrhagic Hemorrhage Humans Intensive Intensive care Intensive Care Units Intubation Ischaemic Ischemia Length of Stay Mechanical ventilation Medicine Medicine & Public Health Meta-analysis Middle Aged Mortality Ostomy Patient outcomes Patients Respiration, Artificial Services Stroke Stroke - surgery Stroke patients Systematic review Tracheostomy Tracheotomy Variables Ventilators United States United Kingdom > UK Tracheostomy Haemorrhagic Stroke Critically ill Mechanical ventilation Ischaemic
ISSN:	1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. Methods We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Results Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0–3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality ( β = − 0.3, 95% CI = − 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). Conclusions In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. Trial registration : PROSPERO—CRD42022351732 registered on 17th of August 2022.
AbstractList	Abstract Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. Methods We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Results Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0–3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = − 0.3, 95% CI = − 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). Conclusions In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. Trial registration: PROSPERO—CRD42022351732 registered on 17th of August 2022. Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality ([beta] = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. PROSPERO-CRD42022351732 registered on 17th of August 2022. Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. Methods We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Results Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0–3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality ( β = − 0.3, 95% CI = − 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). Conclusions In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. Trial registration : PROSPERO—CRD42022351732 registered on 17th of August 2022. Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS.BACKGROUNDStroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS.We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients.METHODSWe searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients.Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS).RESULTSThirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS).In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS.CONCLUSIONSIn this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS.PROSPERO-CRD42022351732 registered on 17th of August 2022.TRIAL REGISTRATIONPROSPERO-CRD42022351732 registered on 17th of August 2022. Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS. Methods We searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients. Results Thirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0-3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality ([beta] = - 0.3, 95% CI = - 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS). Conclusions In this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS. Trial registration: PROSPERO--CRD42022351732 registered on 17th of August 2022. Keywords: Stroke, Tracheostomy, Mechanical ventilation, Ischaemic, Haemorrhagic, Critically ill BackgroundStroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients remains uncertain. We performed a systematic review and meta-analysis of tracheostomy timing and its association with reported all-cause overall mortality. Secondary outcomes were the effect of tracheostomy timing on neurological outcome (modified Rankin Scale, mRS), hospital length of stay (LOS), and intensive care unit (ICU) LOS.MethodsWe searched 5 databases for entries related to acute stroke and tracheostomy from inception to 25 November 2022. We adhered to PRISMA guidance for reporting systematic reviews and meta-analyses. Selected studies included (1) ICU-admitted patients who had stroke (either acute ischaemic stroke, AIS or intracerebral haemorrhage, ICH) and received a tracheostomy (with known timing) during their stay and (2) > 20 tracheotomised. Studies primarily reporting sub-arachnoid haemorrhage (SAH) were excluded. Where this was not possible, adjusted meta-analysis and meta-regression with study-level moderators were performed. Tracheostomy timing was analysed continuously and categorically, where early (< 5 days from initiation of mechanical ventilation to tracheostomy) and late (> 10 days) timing was defined per the protocol of SETPOINT2, the largest and most recent randomised controlled trial on tracheostomy timing in stroke patients.ResultsThirteen studies involving 17,346 patients (mean age = 59.8 years, female 44%) met the inclusion criteria. ICH, AIS, and SAH comprised 83%, 12%, and 5% of known strokes, respectively. The mean time to tracheostomy was 9.7 days. Overall reported all-cause mortality (adjusted for follow-up) was 15.7%. One in five patients had good neurological outcome (mRS 0–3; median follow-up duration was 180 days). Overall, patients were ventilated for approximately 12 days and had an ICU LOS of 16 days and a hospital LOS of 28 days. A meta-regression analysis using tracheostomy time as a continuous variable showed no statistically significant association between tracheostomy timing and mortality (β = − 0.3, 95% CI = − 2.3 to 1.74, p = 0.8). Early tracheostomy conferred no mortality benefit when compared to late tracheostomy (7.8% vs. 16.4%, p = 0.7). Tracheostomy timing was not associated with secondary outcomes (good neurological outcome, ICU LOS and hospital LOS).ConclusionsIn this meta-analysis of over 17,000 critically ill stroke patients, the timing of tracheostomy was not associated with mortality, neurological outcomes, or ICU/hospital LOS.Trial registration: PROSPERO—CRD42022351732 registered on 17th of August 2022.
ArticleNumber	132
Audience	Academic
Author	Rocco, Patricia R. M. Camarda, Christopher Godoy, Daniel Agustin Cho, Sung-Min Cuthbertson, Brian H. Robba, Chiara Pelosi, Paolo Battaglini, Denise Suarez, Jose I. Premraj, Lavienraj White, Nicole
Author_xml	– sequence: 1 givenname: Lavienraj surname: Premraj fullname: Premraj, Lavienraj organization: Griffith University School of Medicine, Gold Coast, Critical Care Research Group, The Prince Charles Hospital – sequence: 2 givenname: Christopher surname: Camarda fullname: Camarda, Christopher organization: Griffith University School of Medicine, Gold Coast – sequence: 3 givenname: Nicole surname: White fullname: White, Nicole organization: Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, School of Public Health and Social Work, Queensland University of Technology (QUT) – sequence: 4 givenname: Daniel Agustin surname: Godoy fullname: Godoy, Daniel Agustin organization: Neurointensive Care Unit, Critical Care Department, Sanatorio Pasteur – sequence: 5 givenname: Brian H. surname: Cuthbertson fullname: Cuthbertson, Brian H. organization: Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, University Department of Anaesthesiology in Pain Medicine, University of Toronto – sequence: 6 givenname: Patricia R. M. surname: Rocco fullname: Rocco, Patricia R. M. organization: Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro – sequence: 7 givenname: Paolo surname: Pelosi fullname: Pelosi, Paolo organization: IRCCS Ospedale Policlinico San Martino, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa – sequence: 8 givenname: Chiara surname: Robba fullname: Robba, Chiara organization: IRCCS Ospedale Policlinico San Martino, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa – sequence: 9 givenname: Jose I. surname: Suarez fullname: Suarez, Jose I. organization: Division of Neurosciences Critical Care, Department of Neurology, Neurosurgery, Anaesthesiology and Critical Care Medicine and Neurosurgery, Johns Hopkins University School of Medicine – sequence: 10 givenname: Sung-Min surname: Cho fullname: Cho, Sung-Min organization: Division of Neurosciences Critical Care, Department of Neurology, Neurosurgery, Anaesthesiology and Critical Care Medicine and Neurosurgery, Johns Hopkins University School of Medicine – sequence: 11 givenname: Denise surname: Battaglini fullname: Battaglini, Denise email: battaglini.denise@gmail.com organization: IRCCS Ospedale Policlinico San Martino
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/37005666$$D View this record in MEDLINE/PubMed
BookMark	eNp9Uk1v3CAUtKpUzUf7B3qokHrpxenDYMC9VFHUj0iReknPCDD2srFhC2yr_fdld9MkG1URB9BjZp5mNKfVkQ_eVtVbDOcYC_YxYQItraEhNVCKec1eVCeYMFqLlrRHj97H1WlKSwDMBSOvqmPCAVrG2El1exOVWdiQcpg3KLvZ-REp36OwzibMFjmPTHTZGTVNG-SmCa1UdtbnhP64vEApx3BrPyGFZptVrbyaNsmlncZuEu0YbUou-NfVy0FNyb65u8-qn1-_3Fx-r69_fLu6vLiuDQOR6wYbMrRCKSJaoF1DQdtOt2A1UCB0wD3WRA26xabXzPaCYUUF1wKg54ZQclZd7XX7oJZyFd2s4kYG5eRuEOIoVSyOJitpazkHRqgShjb9oBltdMO1GVTfQQnrrPq811qt9Wx7U4xHNR2IHv54t5Bj-C0xABOYkaLw4U4hhl9rm7KcXTJ2mpS3YZ1kwzvKRMsEFOj7J9BlWMeSaEGVbyCkE_gBNariwPkhlMVmKyovOKUgBO-2a8__gyqnt7MzpUiDK_MDwrvHTu8t_utKATR7gIkhpWiHewgGuS2k3BdSlkLKXSHlliSekIzLpUBhm5abnqeSPTWVPX608SGNZ1h_AWJ38_o
CitedBy_id	crossref_primary_10_5585_22_2023_23445 crossref_primary_10_1016_j_jocn_2023_06_004 crossref_primary_10_1186_s12883_025_04275_5 crossref_primary_10_3390_clinpract15010012 crossref_primary_10_62905_001c_133992 crossref_primary_10_3390_medicina61010087 crossref_primary_10_1007_s12028_023_01778_2 crossref_primary_10_7759_cureus_91415 crossref_primary_10_7759_cureus_52766 crossref_primary_10_1212_WNL_0000000000209721 crossref_primary_10_1080_00207454_2023_2292953 crossref_primary_10_1186_s13054_023_04482_x crossref_primary_10_1111_jocn_17601 crossref_primary_10_1007_s10405_025_00600_4 crossref_primary_10_1097_ACO_0000000000001403 crossref_primary_10_1136_bmjopen_2025_104897 crossref_primary_10_1177_17511437241238877 crossref_primary_10_1007_s00063_024_01184_2 crossref_primary_10_1186_s13054_023_04443_4 crossref_primary_10_1177_00031348251337147 crossref_primary_10_3390_jcm13102729 crossref_primary_10_1016_j_compbiomed_2023_107577 crossref_primary_10_1186_s13054_024_05162_0 crossref_primary_10_1002_lary_32206 crossref_primary_10_3389_fneur_2025_1562454 crossref_primary_10_1097_CCE_0000000000001145 crossref_primary_10_1186_s12890_023_02484_7
Cites_doi	10.1097/CCM.0b013e31821209a8 10.1016/j.clineuro.2019.105419 10.1007/s12028-018-0619-4 10.1161/STROKEAHA.112.669895 10.1007/s12028-012-9709-x 10.1159/000471892 10.1097/MD.0000000000024329 10.4187/respcare.03652 10.1186/s13054-019-2662-8 10.1007/s12028-020-01109-9 10.1111/j.1365-2044.2004.04106.x 10.7326/ACPJC-1995-123-3-A12 10.1001/jama.2022.4798 10.1007/s12028-018-0596-7 10.1007/s00134-020-06283-0 10.1186/1471-2288-5-13 10.18637/jss.v036.i03 10.1016/j.jstrokecerebrovasdis.2013.08.019 10.1007/s12028-010-9346-1 10.1097/MD.0000000000021057 10.1001/jama.2013.5154 10.1186/1471-2288-14-25 10.1016/j.jclinepi.2005.06.006 10.3171/2018.7.JNS181345 10.1016/j.wneu.2019.08.013 10.2147/NDT.S388062 10.1186/s12874-018-0483-0 10.1007/s12028-014-0082-9 10.1183/09031936.02.01342001 10.1007/s12028-015-0235-5 10.1007/s12028-017-0390-y 10.1097/CCM.0000000000005189 10.3389/fneur.2021.728624 10.1016/j.bja.2022.07.032 10.1136/bmj.n71 10.1016/S2213-2600(15)00007-7 10.1016/j.jstrokecerebrovasdis.2013.09.008 10.1002/jrsm.1489 10.1186/s40560-017-0269-1 10.7759/cureus.24059 10.1159/000080771 10.1007/s00701-008-0153-9 10.1007/s12028-011-9539-2 10.1136/bmj.l4898 10.4103/2229-5151.190651 10.1161/STROKEAHA.117.017794
ContentType	Journal Article
Copyright	The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA
DOI	10.1186/s13054-023-04417-6
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic Publicly Available Content Database
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (WRLC) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1364-8535 1466-609X 1366-609X
EndPage	10
ExternalDocumentID	oai_doaj_org_article_45e770634a8c42dfb642b27bcfad9086 PMC10068163 A744088793 37005666 10_1186_s13054_023_04417_6
Genre	Meta-Analysis Systematic Review Journal Article
GeographicLocations	United States United Kingdom--UK
GeographicLocations_xml	– name: United States – name: United Kingdom--UK
GrantInformation_xml	– fundername: NHLBI NIH HHS grantid: K23 HL157610 – fundername: NHLBI NIH HHS grantid: L30 HL165486
GroupedDBID	--- 0R~ 29F 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SJN SMD SOJ SV3 TR2 U2A UKHRP WOQ YOC .6V AAYXX AFFHD CITATION -5E -5G -BR 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM
ID	FETCH-LOGICAL-c608t-21c3f58aa385049240be9b50eb04034f1d1b3afb51cdb6ed861a487b800d7c343
IEDL.DBID	RSV
ISICitedReferencesCount	28
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000961708100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1364-8535 1466-609X
IngestDate	Fri Oct 03 12:53:54 EDT 2025 Tue Nov 04 02:07:06 EST 2025 Thu Oct 02 09:51:13 EDT 2025 Tue Oct 14 12:40:36 EDT 2025 Sat Nov 29 13:08:42 EST 2025 Sat Nov 29 10:21:15 EST 2025 Thu Jan 02 22:38:33 EST 2025 Sat Nov 29 06:02:15 EST 2025 Tue Nov 18 21:17:24 EST 2025 Sat Sep 06 07:24:29 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Tracheostomy Haemorrhagic Stroke Critically ill Mechanical ventilation Ischaemic
Language	English
License	2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c608t-21c3f58aa385049240be9b50eb04034f1d1b3afb51cdb6ed861a487b800d7c343
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Feature-2 ObjectType-Undefined-1 content type line 23 ObjectType-Article-3
OpenAccessLink	https://link.springer.com/10.1186/s13054-023-04417-6
PMID	37005666
PQID	2803033981
PQPubID	44362
PageCount	10
ParticipantIDs	doaj_primary_oai_doaj_org_article_45e770634a8c42dfb642b27bcfad9086 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10068163 proquest_miscellaneous_2794685680 proquest_journals_2803033981 gale_infotracmisc_A744088793 gale_infotracacademiconefile_A744088793 pubmed_primary_37005666 crossref_primary_10_1186_s13054_023_04417_6 crossref_citationtrail_10_1186_s13054_023_04417_6 springer_journals_10_1186_s13054_023_04417_6
PublicationCentury	2000
PublicationDate	2023-04-01
PublicationDateYYYYMMDD	2023-04-01
PublicationDate_xml	– month: 04 year: 2023 text: 2023-04-01 day: 01
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	Critical care (London, England)
PublicationTitleAbbrev	Crit Care
PublicationTitleAlternate	Crit Care
PublicationYear	2023
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V BMC
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC
References	MP Catalino (4417_CR11) 2018; 6 4417_CR23 TA Furukawa (4417_CR30) 2006; 59 S Wahlster (4417_CR9) 2021; 34 Y Shen (4417_CR21) 2022; 18 V Rass (4417_CR48) 2022; 50 4417_CR26 W Chen (4417_CR12) 2019; 131 IL Maier (4417_CR18) 2021; 12 VM da Cruz (4417_CR39) 2002; 20 D Villalba (4417_CR40) 2016; 6 P Kurtz (4417_CR6) 2011; 15 C Steidl (4417_CR7) 2017; 44 J Bösel (4417_CR8) 2022; 327 4417_CR42 YM Chang (4417_CR44) 2020; 99 MR McCann (4417_CR36) 2020; 132 CJ Weir (4417_CR29) 2018; 18 J Bösel (4417_CR10) 2013; 44 J Küchler (4417_CR13) 2019; 184 J Bösel (4417_CR3) 2017; 48 C Robba (4417_CR2) 2020; 46 AA Rabinstein (4417_CR19) 2004; 18 HH Dasenbrock (4417_CR43) 2018; 29 P Pelosi (4417_CR5) 2011; 39 W Viechtbauer (4417_CR33) 2010 4417_CR34 4417_CR14 J IntHout (4417_CR32) 2014; 14 S Lahiri (4417_CR1) 2015; 23 C Robba (4417_CR4) 2019; 23 JAC Sterne (4417_CR27) 2019; 366 JA Villwock (4417_CR22) 2014; 23 S Schönenberger (4417_CR47) 2016; 25 H Schneider (4417_CR20) 2017; 27 K Krishnan (4417_CR24) 2005; 60 WS Richardson (4417_CR25) 1995; 123 O Cinar (4417_CR35) 2021; 12 J Kleffmann (4417_CR41) 2012 V Szeder (4417_CR46) 2010; 13 DR Hallan (4417_CR16) 2022 SP Hozo (4417_CR28) 2005; 5 H Deng (4417_CR38) 2021; 100 K Alsherbini (4417_CR15) 2019; 30 D Battaglini (4417_CR31) 2022 YC Lee (4417_CR17) 2015; 60 BP Walcott (4417_CR45) 2014; 23 II Siempos (4417_CR37) 2015; 3 37264477 - Crit Care. 2023 Jun 1;27(1):216. doi: 10.1186/s13054-023-04482-x 37076935 - Crit Care. 2023 Apr 19;27(1):151. doi: 10.1186/s13054-023-04443-4
References_xml	– volume: 39 start-page: 1482 issue: 6 year: 2011 ident: 4417_CR5 publication-title: Crit Care Med doi: 10.1097/CCM.0b013e31821209a8 – volume: 184 start-page: 105419 year: 2019 ident: 4417_CR13 publication-title: Clin Neurol Neurosurg doi: 10.1016/j.clineuro.2019.105419 – volume: 29 start-page: 326 issue: 3 year: 2018 ident: 4417_CR43 publication-title: Neurocrit Care doi: 10.1007/s12028-018-0619-4 – volume: 44 start-page: 21 issue: 1 year: 2013 ident: 4417_CR10 publication-title: Stroke doi: 10.1161/STROKEAHA.112.669895 – year: 2012 ident: 4417_CR41 publication-title: Neurocrit Care doi: 10.1007/s12028-012-9709-x – volume: 44 start-page: 1 issue: 1–2 year: 2017 ident: 4417_CR7 publication-title: Cerebrovasc Dis doi: 10.1159/000471892 – volume: 100 start-page: e24329 issue: 3 year: 2021 ident: 4417_CR38 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000024329 – volume: 60 start-page: 651 issue: 5 year: 2015 ident: 4417_CR17 publication-title: Respir Care doi: 10.4187/respcare.03652 – volume: 23 start-page: 388 issue: 1 year: 2019 ident: 4417_CR4 publication-title: Crit Care doi: 10.1186/s13054-019-2662-8 – volume: 34 start-page: 956 issue: 3 year: 2021 ident: 4417_CR9 publication-title: Neurocrit Care doi: 10.1007/s12028-020-01109-9 – volume: 60 start-page: 360 issue: 4 year: 2005 ident: 4417_CR24 publication-title: Anaesthesia doi: 10.1111/j.1365-2044.2004.04106.x – volume: 123 start-page: A12 issue: 3 year: 1995 ident: 4417_CR25 publication-title: ACP J Club doi: 10.7326/ACPJC-1995-123-3-A12 – volume: 327 start-page: 1899 issue: 19 year: 2022 ident: 4417_CR8 publication-title: JAMA doi: 10.1001/jama.2022.4798 – volume: 30 start-page: 185 issue: 1 year: 2019 ident: 4417_CR15 publication-title: Neurocrit Care doi: 10.1007/s12028-018-0596-7 – volume: 46 start-page: 2397 issue: 12 year: 2020 ident: 4417_CR2 publication-title: Intensive Care Med doi: 10.1007/s00134-020-06283-0 – volume: 5 start-page: 13 issue: 1 year: 2005 ident: 4417_CR28 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-5-13 – year: 2010 ident: 4417_CR33 publication-title: J Stat Softw doi: 10.18637/jss.v036.i03 – volume: 23 start-page: 1024 issue: 5 year: 2014 ident: 4417_CR45 publication-title: J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc doi: 10.1016/j.jstrokecerebrovasdis.2013.08.019 – volume: 13 start-page: 40 issue: 1 year: 2010 ident: 4417_CR46 publication-title: Neurocrit Care doi: 10.1007/s12028-010-9346-1 – volume: 99 start-page: e21057 issue: 28 year: 2020 ident: 4417_CR44 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000021057 – ident: 4417_CR14 doi: 10.1001/jama.2013.5154 – ident: 4417_CR26 – volume: 14 start-page: 25 issue: 1 year: 2014 ident: 4417_CR32 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-14-25 – volume: 59 start-page: 7 issue: 1 year: 2006 ident: 4417_CR30 publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2005.06.006 – volume: 132 start-page: 87 issue: 1 year: 2020 ident: 4417_CR36 publication-title: J Neurosurg doi: 10.3171/2018.7.JNS181345 – volume: 131 start-page: e606 year: 2019 ident: 4417_CR12 publication-title: World Neurosurg doi: 10.1016/j.wneu.2019.08.013 – volume: 18 start-page: 2713 year: 2022 ident: 4417_CR21 publication-title: Neuropsychiatr Dis Treat doi: 10.2147/NDT.S388062 – volume: 18 start-page: 25 issue: 1 year: 2018 ident: 4417_CR29 publication-title: BMC Med Res Methodol doi: 10.1186/s12874-018-0483-0 – volume: 23 start-page: 28 issue: 1 year: 2015 ident: 4417_CR1 publication-title: Neurocrit Care doi: 10.1007/s12028-014-0082-9 – volume: 20 start-page: 112 issue: 1 year: 2002 ident: 4417_CR39 publication-title: Eur Respir J doi: 10.1183/09031936.02.01342001 – volume: 25 start-page: 94 issue: 1 year: 2016 ident: 4417_CR47 publication-title: Neurocrit Care doi: 10.1007/s12028-015-0235-5 – volume: 27 start-page: 26 issue: 1 year: 2017 ident: 4417_CR20 publication-title: Neurocrit Care doi: 10.1007/s12028-017-0390-y – volume: 50 start-page: 103 issue: 1 year: 2022 ident: 4417_CR48 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000005189 – volume: 12 start-page: 728624 year: 2021 ident: 4417_CR18 publication-title: Front Neurol doi: 10.3389/fneur.2021.728624 – year: 2022 ident: 4417_CR31 publication-title: Br J Anaesth doi: 10.1016/j.bja.2022.07.032 – ident: 4417_CR23 doi: 10.1136/bmj.n71 – volume: 3 start-page: 150 issue: 2 year: 2015 ident: 4417_CR37 publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(15)00007-7 – volume: 23 start-page: 1069 issue: 5 year: 2014 ident: 4417_CR22 publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2013.09.008 – volume: 12 start-page: 537 issue: 4 year: 2021 ident: 4417_CR35 publication-title: Res Synth Methods doi: 10.1002/jrsm.1489 – volume: 6 start-page: 1 issue: 1 year: 2018 ident: 4417_CR11 publication-title: J Intensive Care doi: 10.1186/s40560-017-0269-1 – year: 2022 ident: 4417_CR16 publication-title: Cureus. doi: 10.7759/cureus.24059 – volume: 18 start-page: 325 issue: 4 year: 2004 ident: 4417_CR19 publication-title: Cerebrovasc Dis doi: 10.1159/000080771 – ident: 4417_CR34 – ident: 4417_CR42 doi: 10.1007/s00701-008-0153-9 – volume: 15 start-page: 477 issue: 3 year: 2011 ident: 4417_CR6 publication-title: Neurocrit Care doi: 10.1007/s12028-011-9539-2 – volume: 366 start-page: l4898 year: 2019 ident: 4417_CR27 publication-title: BMJ doi: 10.1136/bmj.l4898 – volume: 6 start-page: 98 issue: 3 year: 2016 ident: 4417_CR40 publication-title: Int J Crit Illn Inj Sci doi: 10.4103/2229-5151.190651 – volume: 48 start-page: 2638 issue: 9 year: 2017 ident: 4417_CR3 publication-title: Stroke doi: 10.1161/STROKEAHA.117.017794 – reference: 37264477 - Crit Care. 2023 Jun 1;27(1):216. doi: 10.1186/s13054-023-04482-x – reference: 37076935 - Crit Care. 2023 Apr 19;27(1):151. doi: 10.1186/s13054-023-04443-4
SSID	ssj0017863
Score	2.5246978
SecondaryResourceType	review_article
Snippet	Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in... Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in stroke patients... Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in... BackgroundStroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on mortality in... Abstract Background Stroke patients requiring mechanical ventilation often have a poor prognosis. The optimal timing of tracheostomy and its impact on...
SourceID	doaj pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	132
SubjectTerms	Acute Stroke Management Artificial respiration Brain Ischemia Care and treatment Cerebral Hemorrhage Critical Care Critical Care Medicine Critical Illness Critically ill Emergency Medicine Extubation Female Haemorrhagic Hemorrhage Humans Intensive Intensive care Intensive Care Units Intubation Ischaemic Ischemia Length of Stay Mechanical ventilation Medicine Medicine & Public Health Meta-analysis Middle Aged Mortality Ostomy Patient outcomes Patients Respiration, Artificial Services Stroke Stroke - surgery Stroke patients Systematic review Tracheostomy Tracheotomy Variables Ventilators
SummonAdditionalLinks	– databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJtAQUZC4gBW4zh-hFtBVFyoOIDUm-VnWXWbrTZZpP57xo53aYqAC9fYiWzP45uJ7W8QetWFRPEiJQH4VqSFgJ-YRkbSRul4iLb2TczFJuTxsTo56b5cKfWVzoRN9MDTwh20PEgJONoa5drGRwsBs22kddH4DuLx5H0h6tkmU2X_QCrBtldklDgYwFPzlgA-kTrV3CJiBkOZrf93n3wFlK4fmLy2a5rB6OguulOiSHw4jf4euhH6--jW57JP_gCdAQSBNBJpxvklHlPlrlNseo9XmxFULOBFj10pcrC8xIvlEheC1QGnP7N4GNers_AOG3weRkNMoS7J38hP1uF0OkHbP0Tfjj5-_fCJlLIKxIlajaShjkWujGGKQ34AkG5DZ3kdLBg0ayP11DITLafOWxG8EtRAWmMhtPTSsZY9Qnv9qg9PELaN57ETMnSmawHZLFh7wz1IBhJHym2F6HaVtSuc46n0xVLn3EMJPUlGg2R0lowWFXqze-diYtz4a-_3SXi7noktOz8AHdJFh_S_dKhCr5PodbJpGJ4z5WoCTDKxY-nDxKII3rhjFdqf9QRbdPPmrfLo4gsGnep_1Yx1ilbo5a45vZnOt_VhtYE-iedfcaHqCj2edG03JSYTX6uAUaqZFs7mPG_pF98zUzhNN4Ag4q7Q263C_hrXnxf16f9Y1GfodjMZHKnpPtob15vwHN10P8bFsH6RzfUn3RJA_g priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgixAX3o9AQUZC4gBW4ziOHS6oRa24sKoQSL1ZtuMsq26TkmSR-u8ZO94tKaIXrrGz68mM5-HH9yH0pnQe4kUIAuFbkhwSfqIzUZO8Fpa72qRVVgeyCTGfy5OT8jguuPXxWOXGJwZHXbXWr5HveRallLFS0o_nP4lnjfK7q5FC4yba8Uhl-QztHBzOj79u9xGEDFxqlBU5gcDEN9dmZLHXg_fmOYGYRVLPw0WKSWgKCP5_--k_AtXVQ5RXdlJDgDq697-i3Ud3Y2qK90dbeoBuuOYhuv0lbr4_QqcQ10DFHonj7AIPng5sgXVT4XY9wB85vGywjcwJqwu8XK1wRG3tsV_uxf3QtafuA9b4zA2a6IiHEn4jPOncYjyW2zxG348Ov336TCJXA7FFKgeSUctqLrVmkkPRAXmCcaXhqTPgJVhe04oapmvDqa1M4SpZUA21koF8tRKW5ewJmjVt454hbLKK12UhXKnLHMKlAReS8UpXJVSjlJsE0Y2alI1A5p5PY6VCQSMLNapWgWpVUK0qEvRu-875CONxbe8Dr_1tTw_BHR603ULFGa1y7oSABC_X0uZZVRuo5EwmjK1hpFAoJuittx3lHQUMz-p43wGE9JBbat9DM4KLL1mCdic9YYLbafPGbFR0ML26tJkEvd42-zf9obnGtWvo48kDJC9kmqCno7FuRWLCg8AWMEo5MeOJzNOWZvkjwI9Tf60I0vgEvd9Y_OW4_v1Rn18vxgt0JxvnIknpLpoN3dq9RLfsr2HZd6_ivP4NP-RSGA priority: 102 providerName: ProQuest
Title	Tracheostomy timing and outcome in critically ill patients with stroke: a meta-analysis and meta-regression
URI	https://link.springer.com/article/10.1186/s13054-023-04417-6 https://www.ncbi.nlm.nih.gov/pubmed/37005666 https://www.proquest.com/docview/2803033981 https://www.proquest.com/docview/2794685680 https://pubmed.ncbi.nlm.nih.gov/PMC10068163 https://doaj.org/article/45e770634a8c42dfb642b27bcfad9086
Volume	27
WOSCitedRecordID	wos000961708100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RBZ dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals (WRLC) customDbUrl: eissn: 1364-8535 dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: DOA dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: 7X7 dateStart: 20150101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: BENPR dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: PIMPY dateStart: 20150101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1364-8535 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017863 issn: 1364-8535 databaseCode: RSV dateStart: 19970401 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLZoixAX9iVQRkZC4gAW2byEW4tawaGjUVk0nCzbcYZRpwmaZJD673l2nIGURYJLpMTPkZe3evkeQs8K6yBeOCdgvgXJweEnKuUVyStuqK10XKaVTzbBp1MxnxezcCmsHU67D1uSXlN7sRbsVQvaluYEbAyJXd4swnbQHpg74cTx9P2n7d4BFywbrsf8tt7IBHmk_l_18U8G6fJhyUs7pt4QHd_8vy7cQjeC44kPek65ja7Y-g66dhK21u-iM7BaMIEOZ-P8Ancu2dcCq7rEzaaDv1u8rLEJeRFWF3i5WuGAydpit5iL227dnNnXWOFz2ymiAtqJ_4f_sraL_tBtfQ99PD768OYtCZkYiGGx6EiamKyiQqlMUAgpwAvQttA0thp0QJZXSZnoTFWaJqbUzJaCJQoiIQ3eaMlNlmf30W7d1PYhwjotaVUwbgtV5GAMNSiIlJaqLCDWTKiOUDJMjjQBptxly1hJH64IJvtRlDCK0o-iZBF6sa3ztQfp-Cv1oZvzLaUD2PYfmvVCBnmVObWcg_uWK2HytKw0xGk65dpU0FIIAyP03HGMdGoAmmdUuM0AnXSAWvLAAS-CAi-yCO2PKEF8zbh44DkZ1EcrXcqwOMuAtyP0dFvsarojcbVtNkDjUgMIykQcoQc9i267lHEH8cqglWLEvKM-j0vq5RcPLp64S0PgpEfo5cDDP9r150F99G_kj9H1tBcDEif7aLdbb-wTdNV865bteoJ2-Jz7p5igvcOj6ex04hdL4G327mT2eeIl_jvFMEsQ
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF9yNQwEggDsVqnMSxg4RQeVSt-hCHIu3N2I6zrLpNyiYL2j_Fb2TsJFtSRG89cE2cyJN8nm8mGc-H0IvMuhYvnBOgb0ESCPiJinhBkoIbZgsd5lHhxSb4wYEYjbLPK-hXvxfGlVX2PtE76rwy7hv5hlNRCuM4E_TdyXfiVKPc39VeQqOFxa5d_ISUrX678xHe78so2vp0-GGbdKoCxKShaEhETVwwoVQsGITHwGjaZpqFVgOe46SgOdWxKjSjJtepzUVKFUT1GiKrnJs4ieG-l9Bl8OPclZDx0TLBo1x45TYapwkBGmT9Jh2RbtTAFSwhwJAkdKpfJB0QodcL-JsV_qDFsyWbZ_7bejrcuvm_Pchb6EYXeOPNdqXcRiu2vIOu7nelBXfREbA2ANj1GTle4MaJnY2xKnNczRswzOJJiU2nCzFd4Ml0iruetDV2H7Nx3cyqI_sGK3xsG0VU1-3F38MfmdlxW3Rc3kNfLsTU-2i1rEr7EGEd5azIUm4zlSUAIg0OMmK5yjPItSnTAaI9LKTp2rQ7tZCp9OmaSGULJQlQkh5KMg3Q-vKak7ZJybmj3zu0LUe6BuP-QDUby85fyYRZziF8TZQwSZQXGvJUHXFtCpgppMEBeuWwKp0bhOkZ1e3mACNdQzG56RpPAoFlcYDWBiPBfZnh6R6msnOftTzFaICeL0-7K11JYGmrOYxx0giCpSIM0IN2cSxNirlrcZvCLMVg2QxsHp4pJ998c3XqNk1BkhKg1_0KO53Xvx_qo_PNeIaubR_u78m9nYPdx-h61PoBEtI1tNrM5vYJumJ-NJN69tR7FIy-XvTK-w2hS6z7
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jb9QwFLagoIoLeyFQwEhIHMBqEsdLuJVlBAJGlVjUm-V1GHWaqWYySP33PDuZoSmLhLjGz4mXt8Z-30PoSe0jxIsQBMy3JBU4_ESXIpAqCMt8MLkrQyo2IcZjeXhYH5zJ4k-33ddHkl1OQ0Rpatq9Exc6EZd8bwmal1UE7A3JYw0twi-iS1UsGhTj9U9fN-cIQnK6TpX5bb-BOUqo_b_q5jPG6fzFyXOnp8koja79_3Suo6u9Q4r3Ow66gS745iba_tgfud9CR2DNYGMj_sbxKW5jEbAJ1o3D81ULX_J42mDb10uYneLpbIZ7rNYljj958bJdzI_8C6zxsW810T0KSnpHerLwk-4ybnMbfRm9-fzqLekrNBDLc9mSsrA0MKk1lQxCDfAOjK8Ny70B3UCrULjCUB0MK6wz3DvJCw0RkgEv1QlLK7qDtpp54-8ibErHQs2Fr3VdgZE0oDhK5rSrIQYtmMlQsd4oZXv48lhFY6ZSGCO56lZRwSqqtIqKZ-jZps9JB97xV-qXcf83lBF4Oz2YLyaql2NVMS8EuHWVlrYqXTAQv5lSGBtgpMB_GXoauUdF9QDDs7rPcoBJRqAttR8BGUGx1zRDuwNKEGs7bF7zn-rVylLFUmI5pbUsMvR40xx7xqtyjZ-vgCaWDJCMyzxDdzp23UyJigj9ymGUcsDIgzkPW5rptwQ6XsRkInDeM_R8zc8_x_XnRb33b-SP0PbB65H68G78_j66UnYSQfJiF221i5V_gC7b7-10uXiYxPwHl1NQyA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tracheostomy+timing+and+outcome+in+critically+ill+patients+with+stroke%3A+a+meta-analysis+and+meta-regression&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Premraj%2C+Lavienraj&rft.au=Camarda%2C+Christopher&rft.au=White%2C+Nicole&rft.au=Godoy%2C+Daniel+Agustin&rft.date=2023-04-01&rft.pub=BioMed+Central&rft.eissn=1364-8535&rft.volume=27&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-023-04417-6&rft.externalDocID=10_1186_s13054_023_04417_6
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon